Morning Market Losers

shares tumbled 85.85 percent to $5.40.

shares dipped 52.90 percent to $0.770.

shares fell 45.58 percent to $1.17.

shares dipped 78.22 percent to $3.85 after the company reported that topline results of its VTI-208 trial failed to meet the primary endpoint for overall survival. Credit Suisse downgraded Vital Therapies from Outperform to Neutral and lowered the price target from $25.00 to $9.00.

shares declined 8.57 percent to $95.05 after dipping 7.58 percent on Friday.

will exclusively offer a fully integrated Netflix experience, including billing, when Netflix Japan launches on September 2.

shares fell 7.93 percent to $30.32 after dropping 3.43 percent on Friday.

shares slipped 6.03 percent to $464.64 after falling 4.13 percent on Friday.

shares slipped 5.70 percent to $45.63 after falling 4.37 percent on Friday.

shares tumbled 4.82 percent to $100.67 after declining 6.12 percent on Friday.